Get access

Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy


  • Disclosures
    The authors state that they have no interests which might be perceived as posing a conflict or bias.

Pierre I. Karakiewicz, MD, FRSC, Assistant Professor, Cancer Prognostics and Health Outcomes Unit, Centre Hospitalier de l‘Universite de Montreal, 1058, rue St-Denis, Montreal, Quebec, Canada H2X 3J4
Tel.: + 1 514 890 8000x35336
Fax: + 1 514 412 7411


Tissue inflammation has been linked to cancer in several disease models. We tested the association between chronic inflammation and prostate cancer (PCa), as well as high-grade prostatic intraepithelial neoplasia (HGPIN), in prostatic needle biopsy specimens.

Tissues from 4526 men, who underwent systematic ultrasound-guided sextant needle biopsies of the prostate, were classified in the following order as PCa, or HGPIN, or chronic inflammation or benign.

PCa was diagnosed in 1633 (36.1%), HGPIN in 535 (11.8%) and chronic inflammation in 347 (7.7%). Chronic inflammation conferred a protective effect from PCa: odds ratio (OR) = 0.20, 95% confidence interval (CI) = 0.15–0.28. Chronic inflammation was also inversely associated with HGPIN: OR = 0.11, 95% CI = 0.05–0.22. The ORs remained virtually unchanged after adjustment for age, serum prostate-specific antigen (PSA), digital rectal examination (DRE) and gland volume.

Chronic inflammation is more frequent in the presence of benign histology than it is in the presence of PCa or HGPIN.

Get access to the full text of this article